These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 20305561)

  • 21. Minimising steroids in lupus nephritis--will B cell depletion pave the way?
    Lightstone L
    Lupus; 2013 Apr; 22(4):390-9. PubMed ID: 23553782
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Lupus-nephritis--diagnosis and treatment].
    Norby GE; Lerang K; Holdaas H; Gran JT; Strøm EH; Draganov B; Os I; Hartmann A; Gilboe IM
    Tidsskr Nor Laegeforen; 2010 Jun; 130(11):1140-4. PubMed ID: 20531500
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent news in the treatment of lupus nephritis.
    Tesar V; Hruskova Z
    Minerva Med; 2012 Aug; 103(4):235-51. PubMed ID: 22805617
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lessons Learned From the Clinical Trials of Novel Biologics and Small Molecules in Lupus Nephritis.
    Furie R; Toder K; Zapantis E
    Semin Nephrol; 2015 Sep; 35(5):509-20. PubMed ID: 26573553
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histopathologic and clinical outcome of rituximab treatment in patients with cyclophosphamide-resistant proliferative lupus nephritis.
    Gunnarsson I; Sundelin B; Jónsdóttir T; Jacobson SH; Henriksson EW; van Vollenhoven RF
    Arthritis Rheum; 2007 Apr; 56(4):1263-72. PubMed ID: 17393458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis.
    Ginzler EM; Dooley MA; Aranow C; Kim MY; Buyon J; Merrill JT; Petri M; Gilkeson GS; Wallace DJ; Weisman MH; Appel GB
    N Engl J Med; 2005 Nov; 353(21):2219-28. PubMed ID: 16306519
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent progress in the treatment of lupus nephritis.
    Fanouriakis A; Krasoudaki E; Tzanakakis M; Boumpas DT
    Mod Rheumatol; 2012 Nov; 22(6):803-13. PubMed ID: 22584472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human clinical trials in lupus nephritis.
    Dooley MA; Falk RJ
    Semin Nephrol; 2007 Jan; 27(1):115-27. PubMed ID: 17336693
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Renal involvement in systemic lupus erythematosus].
    Karras A
    Presse Med; 2012 Mar; 41(3 Pt 1):260-6. PubMed ID: 22192934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical guideline for the treatment of lupus nephritis and single-centre results of mycofenolate mofetil among patients with lupus nephritis in the National Institute of Rheumatology and Physiotherapy, Budapest].
    Szabó MZ; Kiss E
    Orv Hetil; 2016 Aug; 157(35):1385-93. PubMed ID: 27569461
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A prospective multicentre study of mycophenolate mofetil combined with prednisolone as induction therapy in 213 patients with active lupus nephritis.
    F L; Y T; X P; L W; H W; Z S; H Z; Z H;
    Lupus; 2008 Jul; 17(7):622-9. PubMed ID: 18625634
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sequential therapies for proliferative lupus nephritis.
    Contreras G; Pardo V; Leclercq B; Lenz O; Tozman E; O'Nan P; Roth D
    N Engl J Med; 2004 Mar; 350(10):971-80. PubMed ID: 14999109
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differences in rituximab use between pediatric rheumatologists and nephrologists for the treatment of refractory lupus nephritis and renal flare in childhood-onset SLE.
    Gilbert M; Goilav B; Hsu JJ; Nietert PJ; Meidan E; Chua A; Ardoin SP; Wenderfer SE; von Scheven E; Ruth NM;
    Pediatr Rheumatol Online J; 2021 Aug; 19(1):137. PubMed ID: 34461932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Top 10 developments in lupus nephritis.
    Chen TK; Fine DM
    Curr Rheumatol Rep; 2013 Sep; 15(9):358. PubMed ID: 23893235
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment options for severe lupus nephritis.
    Lenz O; Contreras G
    Arch Immunol Ther Exp (Warsz); 2004; 52(5):356-65. PubMed ID: 15507877
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent Advances in Treatment Strategies for Lupus Nephritis.
    Karasawa K; Uchida K; Takabe T; Moriyama T; Nitta K
    Contrib Nephrol; 2018; 195():42-50. PubMed ID: 29734149
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and immunological effects of Rituximab in patients with lupus nephritis refractory to conventional therapy: a pilot study.
    Vigna-Perez M; Hernández-Castro B; Paredes-Saharopulos O; Portales-Pérez D; Baranda L; Abud-Mendoza C; González-Amaro R
    Arthritis Res Ther; 2006; 8(3):R83. PubMed ID: 16677395
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction therapy for pediatric focal proliferative lupus nephritis: cyclophosphamide versus mycophenolate mofetil.
    Lau KK; Ault BH; Jones DP; Butani L
    J Pediatr Health Care; 2008; 22(5):282-8. PubMed ID: 18761229
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lupus nephritis: treatment with mycophenolate mofetil.
    Kapitsinou PP; Boletis JN; Skopouli FN; Boki KA; Moutsopoulos HM
    Rheumatology (Oxford); 2004 Mar; 43(3):377-80. PubMed ID: 14963204
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rituximab in the treatment of refractory lupus nephritis with vasculitis.
    Kadikoy H; Haque W; Ahmed S; Abdellatif A
    Saudi J Kidney Dis Transpl; 2012 Mar; 23(2):334-7. PubMed ID: 22382230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.